BioLife Solutions completes $73.0 million sale of SciSafe unit, amends bylaws
BioLife Solutions completed the sale of its SciSafe subsidiary to Subzero Purchaser Corp. on November 12, 2024, for an aggregate price of $73.0 million, subject to adjustment. The same day, the company amended and restated its bylaws, including lowering the stockholder meeting quorum to one-third of voting power. The unaudited pro forma figures in the filing show a $39.6 million gain on the sale as of June 30, 2024, and SciSafe will be reported as discontinued operations from 2024 onward.
Key points
- Sale of SciSafe to Subzero Purchaser Corp. closed November 12, 2024, for $73.0 million, subject to adjustment
- BioLife paid former SciSafe stockholders about $3.3 million to waive certain earn-out payments and repaid about $0.9 million of SciSafe debt
- Silicon Valley Bank loan amendment dated November 11, 2024 adds a $750,000 non-refundable termination fee
- Amended bylaws, adopted November 12, 2024, set stockholder meeting quorum at one-third of voting power and add a Delaware exclusive forum provision
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:07 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 12, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.